Broadfin Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-610,414
| Closed | -$7.08M | – | 42 |
|
2019
Q3 | $7.08M | Sell |
610,414
-442,900
| -42% | -$5.13M | 1.31% | 17 |
|
2019
Q2 | $21.2M | Buy |
1,053,314
+37,200
| +4% | +$747K | 4.6% | 5 |
|
2019
Q1 | $23M | Hold |
1,016,114
| – | – | 4.75% | 6 |
|
2018
Q4 | $23M | Buy |
1,016,114
+77,900
| +8% | +$1.76M | 3.02% | 5 |
|
2018
Q3 | $27M | Sell |
938,214
-110,479
| -11% | -$3.17M | 3.97% | 5 |
|
2018
Q2 | $28.6M | Sell |
1,048,693
-129,533
| -11% | -$3.53M | 4.5% | 6 |
|
2018
Q1 | $26.3M | Sell |
1,178,226
-463,642
| -28% | -$10.4M | 4.11% | 7 |
|
2017
Q4 | $34.6M | Sell |
1,641,868
-75,090
| -4% | -$1.58M | 5.65% | 4 |
|
2017
Q3 | $42.7M | Sell |
1,716,958
-1,145,220
| -40% | -$28.5M | 6.32% | 3 |
|
2017
Q2 | $55.5M | Sell |
2,862,178
-30,000
| -1% | -$582K | 6.74% | 2 |
|
2017
Q1 | $53.4M | Sell |
2,892,178
-377,093
| -12% | -$6.96M | 6.47% | 3 |
|
2016
Q4 | $61.9M | Sell |
3,269,271
-200,000
| -6% | -$3.79M | 6.87% | 3 |
|
2016
Q3 | $77.6M | Buy |
3,469,271
+806,680
| +30% | +$18.1M | 6.96% | 2 |
|
2016
Q2 | $47.4M | Sell |
2,662,591
-297,199
| -10% | -$5.29M | 4.61% | 4 |
|
2016
Q1 | $40.4M | Hold |
2,959,790
| – | – | 3.9% | 4 |
|
2015
Q4 | $57.1M | Buy |
2,959,790
+350,000
| +13% | +$6.75M | 3.51% | 5 |
|
2015
Q3 | $52.9M | Buy |
2,609,790
+446,862
| +21% | +$9.05M | 2.94% | 4 |
|
2015
Q2 | $71.7M | Sell |
2,162,928
-799,370
| -27% | -$26.5M | 3.85% | 4 |
|
2015
Q1 | $71M | Buy |
2,962,298
+303,444
| +11% | +$7.27M | 5.53% | 3 |
|
2014
Q4 | $32.5M | Buy |
2,658,854
+100,000
| +4% | +$1.22M | 2.83% | 8 |
|
2014
Q3 | $22.9M | Buy |
2,558,854
+883,603
| +53% | +$7.9M | 2.4% | 13 |
|
2014
Q2 | $24.9M | Buy |
1,675,251
+65,555
| +4% | +$974K | 2.43% | 14 |
|
2014
Q1 | $34.1M | Buy |
+1,609,696
| New | +$34.1M | 3.31% | 6 |
|